Showing results (31-40 of 298) with videos related to
Sort By:
Pageof 30
Nagoya Journal of Medical Science|August 6, 2025
Durvalumab-combined chemotherapy for biliary tract cancer in a Japanese expert center: initial 50 cases in daily practiceYoshikuni Inokawa, Shunsuke Onoe, Shoji Kawakatsu, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 2003
[Treatment strategy of localized prostate cancer]Osamu MaedaNagoya Journal of Medical Science|December 14, 2020
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature reviewOsamu Maeda, Fumiharu Ohka, Satoshi Maesawa, et al.Drug Metabolism Reviews|November 1, 2005
Clinical pharmacogenetics of irinotecan (CPT-11)Yuichi Ando, Yoshinori HasegawaScientific Reports|October 14, 2020
Gap between pediatric and adult approvals of molecular targeted drugsSatoshi Nishiwaki, Yuichi AndoInternational Journal of Cancer|December 18, 2019
Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: A prospective cohort studyHiroshi Urakawa, Yuichi Ando, Tetsunari Hase, et al.Frontiers in Medicine|January 10, 2022
COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global PerspectiveSatoshi Nishiwaki, Yuichi AndoGan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Chemotherapy for Older Patients with Cancer]Ayako Mitsuma, Yuichi AndoGan to Kagaku Ryoho. Cancer & Chemotherapy|March 16, 2017
[Nephropathy in Patients Undergoing Cancer Drug Therapy - Platinum Derivatives(Cisplatin and Carboplatin)]Ayumu Matsuoka, Yuichi AndoRinsho Byori. the Japanese Journal of Clinical Pathology|November 24, 2015
[UGT1A1 Genotyping for Proper Use of Irinotecan]Ayumu Matsuoka, Yuichi AndoPageof 30